drug screening
Joint Venture From SEngine, Gustave Roussy Aims to Commercialize Cancer Dx Test Across Europe
Premium
SEngine's PARIS test combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis.
At the Association for Molecular Pathology annual meeting, cancer researcher William Hahn talked about efforts to map cancer fitness genes at the genome scale.
Singapore's Avatamed Raises $1M in Seed Funding
Avatamed will use the funds to expand into the Asia-Pacific market and set up a lab in Singapore to provide precision cancer drug screening services.
SEngine Organoid Testing Leads to Treatment Change for Two Metastatic Colorectal Cancer Patients
The researchers said their new study supports the clinical utility of their test, which combines genomic and drug screening analyses of organoids to guide cancer treatment.
Glioblastoma Brain Tumor Treatment Strategies Stem From Pharmacogenomic Analysis
By screening more than 1,500 drugs against patient-derived glioblastoma cells, researchers tracked down tumor alterations with apparent ties to proteasome inhibitor response.